Revised 2016/17 recommendations for FluMist Quadrivalent intranasal vaccine use in childrenEvidence does not support preferential use in children and adolescents 2–17 years of age. Updated Canadian guidelines on managing and treating HIV and hepatitis C co-infectionAddress patient workup and treatment, antiviral recommendations and drug interactions. HIV: Antiretroviral therapy protects partners Epclusa for chronic hepatitis C Once-daily combo tablet provides high cure rates for all six hepatitis C genotypes. Updated Canadian recommendations on HPV vaccines Provides guidance on use of 9-valent vaccine and clarifies minimum intervals between vaccine doses. HPV vaccination reduces cervical abnormalities in young women, study finds Those immunized as girls found to have 50% lower risk than unvaccinated counterparts. Committee recommends against US use of FluMist intranasal influenza vaccine due to lack of efficacy Recommendation still must be approved by the US CDC before being officially adopted. The lowdown on Lyme disease Is science getting trampled in federal efforts to tackle the growing threat of Lyme disease? When should antiretroviral therapy be started in HIV-infected patients? AMMI Canada issues position statement on early use of antiretroviral therapy. Specialty pharmacy services help patients with HIV infection Pharmacists and pharmacy technicians make important contributions to HIV patient care. First Previous 89 90 91 92 93 Next Last
